p-aminoazobenzene has been researched along with tamoxifen in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acar, A; Alférez, DG; Andó, S; Brennan, K; Catalano, S; Chemi, F; Clarke, RB; Eyre, R; Farnie, G; Gandhi, A; Gee, J; Howell, A; Howell, SJ; Landberg, G; Marangoni, E; O'Brien, CS; Rydén, L; Santiago-Gómez, A; Sarmiento-Castro, A; Silva, A; Simões, BM; Sims, AH; Spence, K; Ucar, A; Yu, L | 1 |
1 other study(ies) available for p-aminoazobenzene and tamoxifen
Article | Year |
---|---|
Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.
Topics: Aldehyde Dehydrogenase 1 Family; Animals; Antineoplastic Agents, Hormonal; Basic Helix-Loop-Helix Transcription Factors; Benzazepines; Breast Neoplasms; Calcium-Binding Proteins; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Intercellular Signaling Peptides and Proteins; Isoenzymes; Jagged-1 Protein; Membrane Proteins; Mice; Neoplastic Stem Cells; p-Aminoazobenzene; Proto-Oncogene Proteins; Receptor, Notch4; Receptors, Estrogen; Receptors, Notch; Retinal Dehydrogenase; Serrate-Jagged Proteins; Signal Transduction; Survival Analysis; Tamoxifen; Transcription Factor HES-1; Xenograft Model Antitumor Assays | 2015 |